XORTX Therapeutics Inc.
XRTX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.90M | 2.47M | 2.30M | 3.08M | 3.84M |
| Total Receivables | 17.30K | 17.60K | 13.10K | 22.80K | 30.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 190.90K | 369.70K | 96.50K | 207.30K | 639.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.20K | -- | 48.10K | 157.10K |
| Total Current Assets | 2.10M | 2.68M | 2.41M | 3.36M | 4.66M |
|
|
|||||
| Total Current Assets | 2.10M | 2.68M | 2.41M | 3.36M | 4.66M |
| Net Property, Plant & Equipment | 15.30K | 34.70K | 54.20K | 73.80K | 22.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 180.00K | 183.10K | 185.70K | 168.90K | 166.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M |
| Total Assets | 3.50M | 4.09M | 3.85M | 4.80M | 6.05M |
|
|
|||||
| Total Accounts Payable | 354.00K | 231.20K | 110.70K | 270.00K | 185.10K |
| Total Accrued Expenses | 61.70K | 63.20K | 215.50K | 168.00K | 141.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.70K | 38.80K | 61.50K | 83.70K | 14.00K |
| Total Finance Division Other Current Liabilities | 326.00K | 572.00K | 1.33M | 1.57M | -- |
| Total Other Current Liabilities | 326.00K | 572.00K | 1.33M | 1.57M | -- |
| Total Current Liabilities | 757.40K | 758.00K | 2.10M | 2.53M | 340.90K |
|
|
|||||
| Total Current Liabilities | 757.40K | 758.00K | 2.10M | 2.53M | 340.90K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 83.70K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 1.33M | 1.57M | 3.22M |
| Total Liabilities | 757.40K | 758.00K | 1.72M | 2.09M | 3.56M |
|
|
|||||
| Common Stock & APIC | 18.91M | 18.49M | 17.87M | 17.87M | 17.87M |
| Retained Earnings | -21.87M | -21.17M | -21.29M | -20.70M | -20.87M |
| Treasury Stock & Other | 5.70M | 6.01M | 5.55M | 5.54M | 5.49M |
| Total Common Equity | 2.74M | 3.34M | 2.13M | 2.70M | 2.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.74M | 3.34M | 2.13M | 2.70M | 2.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.74M | 3.34M | 2.13M | 2.70M | 2.49M |
|
|
|||||